Vo Thomas T. - 28 Jun 2024 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: NUTX
Reported as of: 28 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Jun 2024, 11:37:48 UTC
Prior SEC filing: 30 May 2024
Next SEC filing: 15 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Thomas T. Vo

Key filing fact

Vo Thomas T. filed Form 4 for Nutex Health, Inc. (NUTX) on 28 Jun 2024.

Key facts

This page summarizes Vo Thomas T.'s Form 4 filing for Nutex Health, Inc. (NUTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Jun 2024, 11:37.

Change

Previous filing in this sequence was filed on 30 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUTX transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 28 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each RSU represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

Footnote F2

Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Dr. Vo, dated June 28, 2024, the 150,000 RSUs granted to Dr. Vo will vest in three equal installments vesting 1/3 each on March 1, 2025, March 1, 2026 and March 1, 2027.